Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications.

Jonas Reinold, Francesca Palese, Federico Romanese, Giancarlo Logroscino, Oliver Riedel, Federica E Pisa
Author Information
  1. Jonas Reinold: Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology BIPS, Bremen, Germany. ORCID
  2. Francesca Palese: Department of Medicine, University of Udine, Udine, Italy.
  3. Federico Romanese: Department of Medicine, University of Udine, Udine, Italy.
  4. Giancarlo Logroscino: Neurodegenerative Diseases Unit, Department of Basic Medicine Neuroscience and Sense Organs, Department of Clinical Research in Neurology of the University of Bari at "Pia Fondazione Card. G.Panico" Hospital Tricase, University of Bari, Lecce, Italy.
  5. Oliver Riedel: Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology BIPS, Bremen, Germany.
  6. Federica E Pisa: Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology BIPS, Bremen, Germany. ORCID

Abstract

OBJECTIVES: To evaluate changes in the use of antipsychotics and medications with anticholinergic activity (MACs) during hospitalization in older adults with dementia and factors associated with antipsychotic prescriptions and increased anticholinergic burden (ACB).
METHODS AND DESIGN: This retrospective cohort study included all patients aged 65 years or older with a discharge diagnosis of dementia hospitalized at the university hospital of Udine, Italy, from 2012 to 2014. Medications dispensed within 3 months before and after hospitalization were identified in community-pharmacy dispensations while those prescribed at discharge were collected from Hospital Electronic Medical Records (EMR). ACB was assessed using the Anticholinergic Cognitive Burden score.
RESULTS: Among 1908 patients included, at discharge, 37.0% used one or more antipsychotic (9.4% before and 12.6% after hospitalization), 68.6% used one or more MAC (49.1% and 45.7%, respectively), and ACB of 38.4% of patients increased at discharge mainly because of a higher use of antipsychotics with anticholinergic activity (33% at discharge vs 12% before hospitalization). Prescription of antipsychotics at discharge was associated with prior treatment with antipsychotics (adjusted odds ratio [aOR] 4.85; 95%CI, 3.37-6.97), psychiatric conditions, (4.39; 3.47-5.54) and discharge from surgical department (2.17; 1.32-3.55). An increased ACB was associated with psychiatric conditions (1.91; 1.52-2.39), discharge from surgical (1.75; 1.09-2.80) or medical department (1.50; 1.04-2.17), and with cardiac insufficiency (1.41; 1.00-1.99).
CONCLUSIONS: ACB was higher at discharge, and antipsychotics were the main drivers of this increase. Clinicians treating older adults with dementia should be aware of the risks associated with antipsychotics and that some of these medications may increase the risk of anticholinergic effects.

Keywords

MeSH Term

Aged
Aged, 80 and over
Antipsychotic Agents
Cholinergic Antagonists
Dementia
Female
Hospitals
Humans
Italy
Male
Odds Ratio
Patient Discharge
Retrospective Studies

Chemicals

Antipsychotic Agents
Cholinergic Antagonists

Word Cloud

Created with Highcharts 10.0.0discharge1antipsychoticsanticholinergichospitalizationolderACBadultsdementiaassociatedusemedicationsantipsychoticincreasedpatientsAnticholinergicactivityburdenincludedhospitalCognitiveBurdenscoreusedone4%6%higher43psychiatricconditions39surgicaldepartment17increaseOBJECTIVES:evaluatechangesMACsfactorsprescriptionsMETHODSANDDESIGN:retrospectivecohortstudyaged65 yearsdiagnosishospitalizeduniversityUdineItaly20122014Medicationsdispensedwithin3 monthsidentifiedcommunity-pharmacydispensationsprescribedcollectedHospitalElectronicMedicalRecordsEMRassessedusingRESULTS:Among1908370%91268MAC491%457%respectively38mainly33%vs12%Prescriptionpriortreatmentadjustedoddsratio[aOR]8595%CI37-69747-554232-3559152-27509-280medical5004-2cardiacinsufficiency4100-199CONCLUSIONS:maindriversClinicianstreatingawarerisksmayriskeffectsdementia:Increaseduemedicationpharmacoepidemiology

Similar Articles

Cited By